Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approach
Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Kourosh Zarringhalam1, Yvonne Tay2,3, Prajna Kulkarni4
1Department of Mathematics, University of Massachusetts Boston, Boston, MA, 02125, USA. kourosh.zarringhalam@umb.edu.
Abstract:
Regulation by microRNAs (miRNAs) and modulation of miRNA activity are critical components of diverse cellular processes. Recent research has shown that miRNA-based regulation of the tumor suppressor gene PTEN can be modulated by the expression of other miRNA targets acting as competing endogenous RNAs (ceRNAs). However, the key sequence-based features enabling a transcript to act as an effective ceRNA are not well understood and a quantitative model associating statistical significance to such features is currently lacking. To identify and assess features characterizing target recognition by PTEN-regulating miRNAs, we analyze multiple datasets from PAR-CLIP experiments in conjunction with RNA-Seq data. We consider a set of miRNAs known to regulate PTEN and identify high-confidence binding sites for these miRNAs on the 3' UTR of protein coding genes. Based on the number and spatial distribution of these binding sites, we calculate a set of probabilistic features that are used to make predictions for novel ceRNAs of PTEN. Using a series of experiments in human prostate cancer cell lines, we validate the highest ranking prediction (TNRC6B) as a ceRNA of PTEN. The approach developed can be applied to map ceRNA networks of critical cellular regulators and to develop novel insights into crosstalk between different pathways involved in cancer.
Insights
This study identifies key features of competing endogenous RNAs (ceRNAs) that regulate the tumor suppressor PTEN. Researchers developed a model to predict novel ceRNAs, validating TNRC6B as a PTEN ceRNA in prostate cancer cells.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are crucial regulators of cellular processes.
- Competing endogenous RNAs (ceRNAs) modulate miRNA activity, including regulation of the PTEN tumor suppressor gene.
- Understanding ceRNA mechanisms and sequence features is vital for cancer research.
Purpose of the Study:
- To identify and assess sequence-based features that enable transcripts to act as effective ceRNAs.
- To develop a quantitative model for predicting ceRNAs targeting PTEN.
- To validate predicted ceRNAs in human prostate cancer cell lines.
Main Methods:
- Analysis of PAR-CLIP and RNA-Seq data to identify miRNA binding sites.
- Calculation of probabilistic features based on binding site number and distribution.
- Prediction and experimental validation of novel PTEN ceRNAs.
Main Results:
- Identified key sequence and spatial features of miRNA target recognition.
- Developed a predictive model for ceRNA activity.
- Validated TNRC6B as a novel ceRNA of PTEN in prostate cancer cells.
Conclusions:
- The developed approach can map ceRNA networks for critical cellular regulators.
- This work provides novel insights into pathway crosstalk in cancer.
- Understanding ceRNA networks offers potential for new cancer therapeutic strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation

